Clinical Trial Update: Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluates WBC100 Capsule in relapsed/refractory acute myeloid leukemia. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• WBC100 Capsule

Snippet

Sponsor: Hangzhou Weben Pharma Co., Ltd | Conditions: AML (Acute Myelogenous Leukemia, Relapsed Acute Myelogenous Leukemia | Phase 1 | Status: RECRUITING